The results suggest minimal health status benefits once TR has dropped by three grades, but further research is needed.

Overall age-adjusted mortality rates have fallen, but the poorest parts of the world aren’t sharing in the benefits.

The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.

The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.

The findings highlight the importance of having an EP versed in lead management on the heart valve team, one expert says.

Labels for the Pfizer and Moderna shots, which already caution about myocarditis and pericarditis, will more strongly stress ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

In EARLY TAVR, intervention improved outcomes over waiting in patients with class II or no indications for AVR consideration.

Optimizing CV risk factors before pregnancy appears most important for preventing heart disease decades later.

The procedures are not mutually exclusive, however, and should be considered on a patient-by-patient basis, a researcher says ...

In an early look at SCOT-HEART 2, CCTA led more primary-prevention patients to make changes to reduce their risk of CVD.

In DETECT AS, the passive notifications improved rates of AVR and boosted survival, with bigger gains in women.